Komori
Santen Pharmaceutical (4536) · InitiativeAchieved

Sale of All AVS Shares as Part of Business Portfolio Optimization

First written in 2026-10-01. 1 of 1 entries say "Achieved", first in 2026-10-01. Latest entry: 2026-10-01.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies

This thread is not in a theme yet. When the same subject shows up in other companies' filings, you can compare them here.

Full recordFilings, disclosures and news, newest first
  1. 2026-10-01Achievedwww.nikkei.com
    SANTEN PHARMACEUTICAL CO.,LTD. sold all shares of AVS, its US subsidiary engaged in ophthalmic medical devices, for approximately ¥2 billion as part of its business portfolio optimization.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Santen Pharmaceutical's next results are scheduled for 2026-11-05. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.